In other cancer types, KEAP1 mutations in the first Kelch domain (e.g., G333C in A549 cells) and in the intervention region (IVR, D236H in H460 cells) modified NRF2 signalling and influenced platinum sensitivity [50]. The gene discussed is NFE2L2; the disease is cancer.